Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × MLN 8237 × Clear all

NCT01924260 2022-08-02

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01677559 2018-01-11

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms